Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $89.24 USD
Change Today -0.47 / -0.52%
Volume 2.3M
ESRX On Other Exchanges
Symbol
Exchange
ESRX is not on other exchanges.
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

express scripts holding co (ESRX) Snapshot

Open
$89.76
Previous Close
$89.71
Day High
$90.22
Day Low
$89.09
52 Week High
06/22/15 - $92.46
52 Week Low
07/23/14 - $65.08
Market Cap
65.1B
Average Volume 10 Days
4.1M
EPS TTM
$3.37
Shares Outstanding
729.3M
EX-Date
--
P/E TM
26.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for EXPRESS SCRIPTS HOLDING CO (ESRX)

express scripts holding co (ESRX) Details

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company operates through two segments, PBM and Other Business Operations. The company’s PBM segment’s services include clinical solutions to enhance health outcomes, such as adherence, case coordination, and personalized medicine; specialized pharmacy care; home delivery pharmacy; specialty pharmacy, including the distribution of fertility pharmaceuticals that require special handling or packaging; and retail network pharmacy administration. It also provides benefit design consultation; drug utilization review; drug formulary management; an array of Medicare, Medicaid, and health insurance marketplace; administration of a group purchasing organization; and consumer health and drug information services. In addition, the company distributes specialty pharmaceuticals and medical supplies to providers, clinics, and hospitals; and offers consulting services for pharmaceutical manufacturers to collect scientific evidence to guide the use of medicines, as well as case management approach to manage care by integrating pre-certification, case management, and discharge planning services for patients. It serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, retina specialists, and others. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in St. Louis, Missouri.

29,500 Employees
Last Reported Date: 02/23/15
Founded in 1986

express scripts holding co (ESRX) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.2M
President and Director
Total Annual Compensation: $1.3M
Executive Vice President and General Counsel
Total Annual Compensation: $660.4K
Chief Human Resources Officer and Senior Vice...
Total Annual Compensation: $535.4K
Vice President
Total Annual Compensation: $332.0K
Compensation as of Fiscal Year 2014.

express scripts holding co (ESRX) Key Developments

Express Scripts Holding Company Presents at Barclays Select Series: PBM Drug Pricing & Formulary Management Symposium, Jun-17-2015

Express Scripts Holding Company Presents at Barclays Select Series: PBM Drug Pricing & Formulary Management Symposium, Jun-17-2015. Venue: Barclays, 745 Seventh Avenue, New York City 10019, United States. Presentation Date & Speakers: Jun-17-2015, Everett Neville, Senior Vice President of Supply Chains.

Express Scripts Holding Company Elects Tim Wentworth to Board of Directors

Express Scripts Holding Company announced that its Board of Directors has elected Tim Wentworth to the Board. Mr. Wentworth is currently the President of Express Scripts, a role he has held since 2014. He has management responsibility for all aspects of the company's core business, and reports directly to George Paz, Express Scripts' Chairman and CEO. Prior to his appointment as President, Mr. Wentworth served as Senior Vice President and President, Sales and Account Management, with responsibility for Express Scripts' core sales and account management teams, including employer groups, health plans, and new sales. In addition to sales and account management, he is currently responsible for information technology, operations, research and new solutions, home delivery and specialty pharmacies, and supply chain management.

Express Scripts Holding Company Presents at Leerink Partners Healthcare Services & HCIT Roundtable, Jun-18-2015 10:00 AM

Express Scripts Holding Company Presents at Leerink Partners Healthcare Services & HCIT Roundtable, Jun-18-2015 10:00 AM. Venue: The Palace Hotel, New York, New York, United States. Speakers: Everett Neville, Senior Vice President of Supply Chains.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ESRX:US $89.24 USD -0.47

ESRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aetna Inc $125.51 USD -3.39
Anthem Inc $163.14 USD -2.08
Cardinal Health Inc $84.50 USD -0.45
Kroger Co/The $73.11 USD -0.12
Walgreens Boots Alliance Inc $85.81 USD +0.04
View Industry Companies
 

Industry Analysis

ESRX

Industry Average

Valuation ESRX Industry Range
Price/Earnings 31.6x
Price/Sales 0.6x
Price/Book 3.2x
Price/Cash Flow 30.9x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXPRESS SCRIPTS HOLDING CO, please visit www.express-scripts.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.